Optimizations have costs as well as benefits. Elimination of a genetic disease? Great! Now the cost is more humans to feed, clothe, educate etc. with no assurance the saved lives not will include those who are burdened in some other way. Thus a move up to the red is certainly a slip down as well, in some way. This leads to the question of ‘optimization for who?’ Then you can start deciding what percentage gets the red up and what percentage gets the blue down. There’s no avoiding unintended consequences, only mitigating them.
This is not true in a relevant manner. If we define the u ‘height’ dimension as total utility, than movements upwards will always imply increases in utility. Of course, this is only a ideal situation, since we can’t really assess total utility, but where I’m getting on is that the move up is suppose to mean an increase in utility, and if it is not, then you have to fix it.
Optimizations have costs as well as benefits. Elimination of a genetic disease? Great! Now the cost is more humans to feed, clothe, educate etc. with no assurance the saved lives not will include those who are burdened in some other way. Thus a move up to the red is certainly a slip down as well, in some way. This leads to the question of ‘optimization for who?’ Then you can start deciding what percentage gets the red up and what percentage gets the blue down. There’s no avoiding unintended consequences, only mitigating them.
This is not true in a relevant manner. If we define the u ‘height’ dimension as total utility, than movements upwards will always imply increases in utility. Of course, this is only a ideal situation, since we can’t really assess total utility, but where I’m getting on is that the move up is suppose to mean an increase in utility, and if it is not, then you have to fix it.